National Resource Center for Academic Detailing [NaRCAD]     857.307.3801
NaRCAD
  • About Us
    • Our Team
    • Contact Us
  • Learning Center
    • The AD Core Toolkit >
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
    • Examples of Program Materials
    • News & Media Center
  • The Detailing Directory
  • EVENTS
    • Training Series
    • CONFERENCE SERIES
    • THE CONFERENCE HUB
  • Blog
  • Partner Network
    • Partners by Location
  • About Us
    • Our Team
    • Contact Us
  • Learning Center
    • The AD Core Toolkit >
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
    • Examples of Program Materials
    • News & Media Center
  • The Detailing Directory
  • EVENTS
    • Training Series
    • CONFERENCE SERIES
    • THE CONFERENCE HUB
  • Blog
  • Partner Network
    • Partners by Location

The DETAILS BLOG

Capturing Stories from the Field: Reflections, Challenges, & Best Practices in Clinical Outreach Education

Academic Detailing in a Time of Uncertainty

4/17/2017

0 Comments

 
Picture
Director's Letter | Mike Fischer, MD, MS
The entire health care system is grappling with uncertainty. What will happen to the provisions of the Affordable Care Act? Will clinicians and health systems face major changes in how they are expected to provide care and how they are reimbursed? Will state and local public health agencies have support for the many initiatives undertaken in recent years?

As we wait for answers to these questions, the role of academic detailing is more important than ever. AD programs will face new challenges, and will need to understand how AD can be adapted to fit changing constraints and still have a beneficial impact on clinician engagement, the quality of care, and patient outcomes. At NaRCAD, we look at this unpredictable environment and see a mandate to collaborate and innovate, working with our partners to develop and evaluate novel ways to implement AD.

Picture
​At NaRCAD, we look at this unpredictable environment and see a mandate to collaborate and innovate.

Planning for NaRCAD2017, our annual conference, is well underway, and the call for proposals is open. Submit results of your current work or your ideas for panels and breakout sessions that will let you share your work and inspire colleagues. 

Picture
To keep AD growing and thriving requires an active pipeline of newly trained detailers, which we have just added to with our recent AD Techniques Training on March 30 & 31, 2017. 

This spring’s training class came to Boston to learn the techniques of academic detailing in order to support important interventions, including better use of smoking cessation treatment for patients with serious mental illness, increasing HPV vaccination rates, enhanced safety of opioid prescribing, and improving the care of chronic diseases such as COPD, HIV/AIDS, diabetes, heart failure, and kidney disease.

​Our trainees hailed from Canada, Brazil, and around the U.S., including South Carolina, Rhode Island, Idaho, Massachusetts, Oregon, Texas, Kentucky, Connecticut, and Colorado, bringing their unique experiences and backgrounds to 2 days filled with hands-on learning opportunities. Stay tuned for upcoming details about our Fall 2017 training, to be held this September--dates announced soon!

What continues to motivate us during times of uncertainty is working with the NaRCAD community, and we want 2017 to continue to be a year of even deeper engagement. Submit to the 2017 conference, share your ideas, suggestions, and comments on our blog, or reach out to us directly.  We’re excited to continue to support your work and to build new collaborations--tell us what you need as part of our community of clinical outreach educators. ​-Mike
Biography. Michael Fischer, MD, MS, NaRCAD Director
Dr. Fischer is a general internist, pharmacoepidemiologist, and health services researcher. He is an Associate Professor of Medicine at Harvard and a clinically active primary care physician and educator at Brigham & Women’s Hospital. With extensive experience in designing and evaluating interventions to improve medication use, he has published numerous studies demonstrating potential gains from improved prescribing. Read more.
0 Comments

Countdown to #NaRCAD2016: Improve Care & Health Outcomes with Us!

11/1/2016

0 Comments

 
Director’s Letter: Fall 2016 | Mike Fischer, MD, MS, Director of NaRCAD
When the leaves start to turn here in Boston, we know it’s almost time for NaRCAD’s International Conference on Academic Detailing. This year’s 4th annual conference features several new and exciting sessions we’re excited to share with our community.

​#NaRCAD2016 highlights the work of innovators in academic detailing from many locations and organizations, ranging from large national health systems to small independent programs. 
Picture
​Diverse clinical topics will be featured at our interactive sessions, including pediatric developmental screening, smoking cessation in patients with serious mental illness, opioid misuse and overuse, screening for ADHD, and many others.

​Breakout sessions offer attendees a chance to work closely with leaders in the field, featuring in-depth and hands-on exploration of specific elements of academic detailing. Whether your focus is on training detailers, preparing clinical topic materials, or program evaluation, our dynamic breakout sessions offer a chance to network and acquire new skills.

Picture
Our conference is our largest event of the year, but our team has been busy this fall with other activities. At our Boston-based training in September we welcomed trainees from organizations across the country, all of whom concentrated on learning the techniques of academic detailing.

We also spent two days this fall in San Francisco, working with the city’s Department of Public Health on an intervention to increase the use of pre-exposure prophylaxis (PrEP) for patients at risk of contracting HIV. We’re excited to continue supporting our partners at the SFDPH as they move forward on this important initiative.

Picture
​Come join us at #NaRCAD2016! There’s only a month left to register, and space is limited. Check out our conference hub archival page to see what previous events were like, including on-demand video and program highlights. We’re excited that clinical outreach education has been such an effective strategy to address the pressing problems facing patients, clinicians, and health systems.

This year, we know that the opportunity to learn, share ideas, and connect with experts will continue to ignite inspiration for our community’s important work in improving quality of care and patient outcomes in 2017 and beyond.

Picture
Biography.
​Michael Fischer, MD, MS  | Director, NaRCAD
Dr. Fischer is a general internist, pharmacoepidemiologist, and health services researcher. He is an Associate Professor of Medicine at Harvard and a clinically active primary care physician and educator at Brigham & Women’s Hospital. With extensive experience in designing and evaluating interventions to improve medication use, he has published numerous studies demonstrating potential gains from improved prescribing. Read more.

0 Comments

A Powerful Intervention: Tobacco Treatment for People with Serious Mental Illness

8/10/2016

4 Comments

 

An Interview with Mass Mental Health Center

Featuring Mark Viron, MD, adult psychiatrist & Director of Health Home Services at the Department of Mental Health’s Massachusetts Mental Health Center (MMHC) in Boston; Assistant Professor at Harvard Medical School.  

​NaRCAD:  We’re excited to talk about your program because it focuses on such an important population, and such a specific topic that’s been a focus of public health initiatives across the nation. Tell us about Massachusetts Mental Health Center (MMHC).
Picture
Mark Viron:  MMHC is a Department of Mental Health (DMH) community mental health center in Boston that has provided mental health services for over 100 years to people with chronic and persistent mental illness. Its ultimate goal is to help people maintain meaningful and productive lives in their community.  In 2013, to better address the significant unmet primary care needs of our patients, we launched the Wellness and Recovery Medicine (WaRM) Center.  The WaRM Center offers co-located and integrated wellness and primary care services for all MMHC patients.




"People with serious mental illness die 25 years earlier than the general population, mostly from preventable [...] conditions."
NaRCAD:  Talk to us about the problem you’re addressing through the Smoke Free Program, which is funded in part through a Behavioral Health Grant from the Massachusetts Attorney General’s Office.

Mark: People with serious mental illness die 25 years earlier than the general population, mostly from preventable and treatable medical conditions such as cardiovascular disease.  More than 30% of people with SMI smoke cigarettes, and tobacco-related illnesses are significant contributors to this egregious mortality disparity.  Reducing smoking among people with SMI may be a powerful intervention for decreasing the mortality gap.
NaRCAD: Why, historically, have rates of tobacco use been higher in folks with serious mental illness (SMI)?  Why has there been resistance for clinicians to promote tobacco cessation for this group?

Mark: It’s a complicated issue.  There are risk factors that increase the rate of smoking in this group and these are coupled with obstacles to getting appropriate treatment.  People with SMI are overrepresented among populations that face social and environmental conditions that are typically associated with an increased prevalence of smoking – poverty, unemployment, limited education, etc.  Obstacles to quitting include limited availability of resources, lack of clinician involvement, and poor social/peer support.
​

​"Attitudes have changed among clinicians, but some harmful myths persist: 'They'll become [...] unstable if they quit.' "
Historically, smoking cessation treatments have been infrequently offered in mental health settings.  Tobacco free policies were slow to develop in psychiatric facilities.  Attitudes have changed among clinicians, but some harmful myths persist: "smoking is their one joy; it's treating their symptoms; they'll become psychiatrically unstable if they quit; it's hopeless to try; none of my patients want to quit; it's not my job to address it."
PictureThe strategy of AD: 1:1 clinician-facing outreach.
NaRCAD: Agreed! What do these AD-focused, 1:1 visits between trained physician educators and psychiatric prescribers entail? 

Mark:  The visits are 20-30 minutes long and follow the typical detailing visit structure. Visits are conducted by me, a psychiatrist at MMHC, or Gail Levine, MD, an internist and the Medical Director of our primary care clinic. 

​We meet with the prescribers in their offices, and begin by asking open-ended questions to assess their needs and learn about their successes (and challenges) in addressing tobacco use with their patients. We celebrate successes and validate challenges, and then pivot to sharing evidence-based information and key messages that may help them address these issues with greater success. We conclude the visit by reviewing steps the prescriber can take to increase successful tobacco treatment, and provide a copy of our detail aid, along with a few high-yield references. 

PictureClick to see complete detail aid.
A key ingredient to our success has been our detail aid.  A great psychiatry resident (now attending), Kathryn Zioto, worked with Gail and me and the NaRCAD team to develop a detail aid about tobacco treatment in people with serious mental illness. 

The detail aid contains cutting-edge, evidence-based information in clear language with colorful graphics. It includes information about the MMHC’S Smoke Free Team, and highlights our three “asks”, which helps clinicians frame their conversations with patients:
​
  • Ask about tobacco use
  • Engage smokers in a discussion
  • Act by referring patients to the Smoke Free Team 


NaRCAD: We enjoyed working on this important project with you, and we know how important great materials are in engaging clinicians to consider behavior change. ​That said, how have psychiatric prescribers been responding?


Mark: The response has been quite favorable.  It's been rewarding to sit down with colleagues and learn from their experience and expertise and to be able to offer some useful information about tobacco treatment and the Smoke Free Program.  The one-on-one detailing encounters, even as brief as they are, give us quality time with our colleagues to focus on their individual concerns and questions.  We probably get as much information as we give! 
Many good ideas have come from these meetings, and we have adapted the Smoke Free Team to respond to concerns and suggestions.  We've seen increases in referrals to the Smoke Free Team, and some prescribers are more actively engaged in the referral and treatment collaboration process, including the prescribing of smoking cessation medications. Time, as a resource, remains our biggest challenge.


​"It's been rewarding... p
rescribers are more actively engaged in the referral and treatment collaboration process."
PictureNaRCAD AD Trainings: hands-on and interactive.
NaRCAD: Two members of your team, yourself and Gail Levine, attended our AD Techniques Training in 2015 to prepare for this initiative. How has the training helped you provide this education to prescribers?

Mark: Your training gave us an in-depth immersion into the world of academic detailing, helping us understand theories and evidence and think about implementation issues.  Getting to practice detailing and getting feedback from experts in the field was invaluable, as was the ability to talk with people from around the country who are working on similar projects.  NaRCAD's training is incredibly worthwhile – it was compact, comprehensive, and helped us acquire the needed skills to implement this project successfully.

NaRCAD: We’re excited that you’ll be sharing your data and results at this fall’s 4th International Conference on Academic Detailing here in Boston on November 14th & 15th. What do you want the clinical education community to know about your program or about AD in general?

Mark:  I think AD provides a robust, evidence-based template for achieving a variety of goals in healthcare.  It’s a process that can foster transformative change in healthcare systems and should be part of an organizational approach to change management in healthcare organizations.



​"AD [...] can foster transformative change in healthcare systems & should be part of an organizational approach to change."
Picture
Provider education, engagement and activation are key, and AD provides a framework that has a proven track record in producing results in these areas.  Plus, AD is efficient and easily implemented relative to other interventions--especially when you have assistance from NaRCAD!

​NaRCAD: Thanks for taking the time to connect with us. We’ve enjoyed helping to support this initiative with training and materials development! We look forward to continuing to learn about the impact you have on improving the health of people with serious mental illness, and sharing it with the community. We can't wait to hear more about this intervention at our conference this fall!

Picture
Biography. Mark Viron, MD is an adult psychiatrist and Director of Health Home Services at the Department of Mental Health’s Massachusetts Mental Health Center (MMHC) in Boston and an Assistant Professor at Harvard Medical School.   He specializes in the treatment of psychotic disorders and the integration of primary and behavioral healthcare for people with serious mental illness. 

​He graduated from Tulane University School of Medicine and completed his psychiatry residency at the Massachusetts General Hospital/McLean Residency Program. He serves as an attending at MMHC’s partial hospital program, where he teaches and trains residents and medical students.  He is also the project director for two grant-funded initiatives that aim to enhance MMHC’s ability to provide integrated primary and behavioral healthcare. 

4 Comments

    Highlighting Best Practices

    We highlight what's working in clinical education through interviews, features, event recaps, and guest blogs, offering clinical educators the chance to share successes and lessons learned from around the country & beyond.

    Search Archives
    by Topic:

    All
    21st Century Cures Act
    5 Year Anniversary
    80% By 2018 Campaign
    Academic Detailing
    Addiction
    ADHD
    Affordable Care Act
    AHRQ
    AIDS
    Alaska
    Alosa Health
    Alternative Facts
    American Academy Of Pediatrics
    American Cancer Society
    Annual Community Survey
    Antibiotics
    Apply To Present
    Aspirin
    Atrius
    Autism
    Autism Screening
    Behavior Change
    Best Practices
    Big Data
    Blood Pressure
    Boston
    Breast Cancer
    California
    Cancer Roundtable
    Cancer Screening
    Cardiology
    Cardiovascular Health
    Care Delivery
    CDC
    Centers For Disease Control
    Cholesterol
    Chronic Disease
    Chronic Illness
    Clinical Education
    Clinical Outreach Education
    Clinical Pharmacists
    Clinical Pharmacy
    Clinician
    Clinician Education
    Clinicians
    CME
    Coaching
    Collaboration
    Colorado
    Colorado ABCD
    Colorado Department Of Public Health And Environment
    Colorectal Cancer
    Communications Skills
    Community-based
    Compliance
    Conference
    Conference Series
    Connecticut
    Consultation
    COPD
    COrE Series
    Cost Savings
    Cultural Competency
    CVS Health
    Data
    Decision Making
    Denver
    Department Of Health
    Dependence
    Depression
    Detailing Aid
    Developmental Delays
    Diabetes
    Director's Letter
    Drug Approval
    Drug Costs
    Drug Regulation
    Drugs
    Drug Safety
    Early Childhood Development
    Education
    Educational Materials
    Efficacy
    Engagement
    Evaluating Evidence
    Evaluation
    Event
    Events
    Evidence
    Evidence-based
    Evidence Based Medicine
    Evidence-based Medicine
    Expert Insight Series
    Expert Panels
    Fall 2016 Training
    Fall 2017 Training
    FDA
    Florida
    Former Trainee
    Formularies
    Gaining Access
    Gatekeeper
    Geronotology
    Getting To Zero
    Guest Blog
    Healthcare
    Healthcare Improvement
    Healthcare Reform
    Health Care System
    Healthcare Transformation
    Health System
    Health Systems
    HealthTeamWorks
    Heart Disease
    Heart Failure
    HEDIS
    HepC
    HIV
    HPV
    Hypertension
    Idaho
    IDIS
    Incontinence
    Interactivity
    Interdisciplinary
    Interview
    Jerry Avorn
    Kaiser Permanente
    Kentucky
    Key Messages
    Keynote Speakers
    Kidney Disease
    LaNet
    LA Net
    Las Vegas
    Learning Center
    Letter
    Lifestyle Management
    Local Response
    Long-term Care
    Los Angeles
    Lung Disease
    Mammography
    Manchester
    Massachusetts
    Massachusetts Department Of Health
    MAT
    Materials Development
    Medical Centers
    Medication
    Medication Assisted Treatment
    Medicine
    Mental Health
    Messaging
    Michigan
    Mississippi
    Morphine Milligram Equivalents
    NACCHO
    Naloxone
    #NaRCAD2014
    #NaRCAD2015
    #NaRCAD2016
    #NaRCAD2017
    #NaRCAD2018
    National AD Service
    Needs Assessment
    Networking
    Nevada
    New Hampshire
    New Mexico
    New York
    North Carolina
    NYDOHMH
    Obesity
    Ohio
    Oklahoma
    On The Road
    Opioid
    Opioid Crisis
    Opioids
    Opioid Use Disorder
    Oregon
    Outreach
    Outreach Education
    Overdose
    Overdose Prevention
    Overprescribing
    Pain Medication
    Partner Network
    Patient Care
    Patients
    PCORI
    PDMP
    PDSA Cycle
    Pediatrics
    Pediatric Screening
    Pennsylvania
    Pertussis
    Pharma
    Pharmaceutial
    Pharmaceutical
    Pharmaceuticals
    Pharmacology
    Pharmacotherapy
    Pharmacy
    Pharmageddon
    Pilot Project
    Policy
    Polypharmacy
    Practice-centered
    Practice Facilitation
    Pregnancy
    Pregnancy-related Depression
    Prenatal Health
    PrEP
    Prescribers
    Prescribing
    Prescribing Guidelines
    Prescription Drug Management
    Prescriptions
    Prevention
    Primary Care
    Primary Care Burnout
    Prisoner Health
    Program Evaluation
    Program Management
    Project PrIDE
    Provider Education
    Providers
    PTSD
    Public Health
    Pulmonology
    Quality Improvement
    RAPID
    Readmission
    Referral
    Registration Open
    Research
    Research Study
    Resources
    Rhode Island
    Role Play
    Rural AD Programs
    Safe Prescribing Guidelines
    San Francisco
    San Francisco Department Of Public Health
    Save The Date
    Scaling Up
    Screening
    Serious Mental Illness
    Sexual Health
    SFDPH
    Smoking Cessation
    Social Marketing
    Social Marketing Skills
    Stakeholders
    Statins
    STDs
    Strategies
    Stroke
    Team Approach
    Technical Assistance
    Technology
    Tennessee
    Texas
    The New Yorker
    Tobacco Treatment
    Total Quality Management
    Training
    Training And Support
    Training Recap
    Training Series
    Transgender
    Transitional Care
    Treatment
    Trends
    VA
    Vaccination
    Vaccinations
    Vermont
    Veterans
    Veterans Affairs
    Veterans Health
    Virginia
    Washington D.C.
    Washington State
    West Virginia
    Workshop
    Zika Virus

    RSS Feed

Picture

​NaRCAD is a program of the Division of Pharmacoepidemiology & Pharmacoeconomics [DoPE], Department of Medicine at Brigham & Women's Hospital and Harvard Medical School, and is funded by  the Agency for Healthcare Research and Quality [AHRQ].

Proudly powered by Weebly